Thymidine Phosphorylase Activity and Prodrug Effects in a Three-Dimensional Model of Angiogenesis: Implications for the Treatment of Ovarian Cancer

This publication has 32 references indexed in Scilit:

• Potent inhibitory effects of steroids in an in vitro model of angiogenesis
  Journal of Endocrinology, 1996
• Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy
  American Journal of Obstetrics and Gynecology, 1995
• Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor
  JNCI Journal of the National Cancer Institute, 1994
• Fibronectin promotes the elongation of microvessels during angiogenesis in vitro
  Journal of Cellular Physiology, 1993
• Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity
  Biochemistry, 1992
• Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
  Biochemical and Biophysical Research Communications, 1992
• Human platelet‐derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase
  Protein Science, 1992
• Induction of angiogenesis during the transition from hyperplasia to neoplasia
  Nature, 1989
• Inhibition of Thymidylatc Synthase After Administration of Doxifluridine in a Transplantable Colon Carcinoma in the Rat
  Cancer Investigation, 1988
• Comparison of the pyrimidine nucleoside phosphorylase activity in human tumors and normal tissues
  Experimental pathology, 1988